Science

Mar 4, 2025, 10:05

Myeloma Paper of the Day, March 4th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CD8 T cells with a transgenic TCR targeting a peptide derived from BOB1 in context of HLA-B*07:02 + a BCMA-targeting CAR enhances efficacy, but CAR-mediated target recognition may limit TCR-mediated target recognition.”

“CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells”

Authors: Tassilo Wachsmann, Teuntje Poortvliet, Miranda Meeuwsen, Dennis Remst, Marijke Toes, Anne Wouters, Renate Hagedoorn, Frederik Falkenburg, and Mirjam Heemskerk.

More posts featuring Robert Orlowski.

Anne Wouters cancer Dennis Remst Frederik Falkenburg Marijke Toes Miranda Meeuwsen Mirjam Heemskerk Myeloma Paper of the Day OncoDaily Oncology Renate Hagedoorn Robert Orlowski Tassilo Wachsmann Teuntje Poortvliet

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage